NATECAL D3

This brand name is authorized in France, Italy, Tunisia, United Kingdom

Active ingredients

The drug NATECAL D3 contains a combination of these active pharmaceutical ingredients (APIs):

1 Calcium carbonate UNII H0G9379FGK - CALCIUM CARBONATE

Calcium carbonate releases, in a pH-dependent manner, calcium ions in the stomach. Calcium carbonate is widely used as antacid and extensively used as a dietary supplement. Read about Calcium carbonate

2 Vitamin D3 UNII 1C6V77QF41 - CHOLECALCIFEROL

In its biologically active form vitamin D3 stimulates intestinal calcium absorption, incorporation of calcium into the osteoid, and release of calcium from bone tissue. In the small intestine it promotes rapid and delayed calcium uptake. The passive and active transport of phosphate is also stimulated. Read about Vitamin D3

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
A12AX	Calcium, combinations with vitamin D and/or other drugs	A Alimentary tract and metabolism → A12 Mineral supplements → A12A Calcium
Discover more medicines within A12AX

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: FR	Base de données publique des médicaments	Identifier(s): 62570701
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 127766
Country: IT	Agenzia del Farmaco	Identifier(s): 034899017, 034899043
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 2033021